Anthony Busti, MD, PharmD, MSc, FNLA, FAHA
This Is Why with Dr. Busti
This Is Why exists to help medical professionals understand the why behind the decisions they make every day in patient care. Our approach is about integrating evidence, clinical relevance and real-world application so that what your learn connects directly with the patients you serve.
Be sure to visit the podcast's website and support the creator: thisiswhy.health
Author
Anthony Busti, MD, PharmD, MSc, FNLA, FAHA
Category
Podcast website
Latest episode
Nov 17, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
LAMA (Long-Acting Muscarinic Antagonists) Bronchodilators for COPD 27.01.2026 26:14
In this lecture from This is Why, Dr. Busti will explain the COPD maintenance inhalers you’ll actually see in practice. In this pharmacology review, we break down LAMA (long-acting muscarinic antagonist) bronchodilators—one of the most important bronchodilator classes for COPD treatment—so you can confidently understand the drugs, the mechanism, and the real-world clinical use. You’ll learn how to...
SAMA (Short-Acting Muscarinic Antagonists) Bronchodilator Pharmacology 27.01.2026 24:10
Short-acting muscarinic antagonists (SAMAs) are a core bronchodilator drug class you’ll see constantly in COPD care. In this lecture from This is Why, Dr. Busti will learn about short-acting muscarinic antagonists (SAMAs) are a core bronchodilator drug class you’ll see constantly in COPD care—and on exams like the NCLEX. In this lecture, you’ll learn exactly how SAMAs work, when to use them, and w...
GLP-1 Receptor Agonists (eg, Semaglutide) Diabetes Pharmacology Review 27.01.2026 46:47
Understand the GLP-1 receptor agonists—and why agents like semaglutide (Ozempic/Wegovy/Rybelsus), liraglutide, dulaglutide, and exenatide have become one of the most talked-about type 2 diabetes medications in modern practice. In this lecture from This is Why, Dr. Busti will break GLP-1s down in a clear, clinically relevant way so you can confidently explain how they work, when to use them, and wh...
Insulin Types: Rapid, NPH, Basal for Diabetes - Pharmacology Review 27.01.2026 1:00:54
Insulin doesn’t have to be confusing when learning how to treat Type 1 and Type 2 diabetes mellitus. In this lecture from This is Why, Dr. Busti will explain how to quickly recognize insulin types, predict onset/peak/duration, and apply basal–bolus dosing concepts to real-world Type 1 and Type 2 diabetes care. You’ll learn how to: - How to identify rapid-, short-, intermediate-, and long-acting in...
Meglitinides (Nateglinide & Repaglinide): Diabetes Pharmacology Review 27.01.2026 13:19
Meglitinides (Nateglinide & Repaglinide) can feel like the “forgotten” oral diabetes drugs—but they show up on exams, in real-world medication histories, and in questions about postprandial glucose control and hypoglycemia and weight gain risk. In this lecture from This is Why, Dr. Busti will explain the meglitinides in a clear, clinically relevant way so you can recognize them quickly and use...
SGLT2 Inhibitors (eg, Empagliflozin) for Diabetes: Pharmacology Review 27.01.2026 35:36
SGLT2 inhibitors (bexagliflozin, canagliflozin, dapagliflozin, empagliflozin, ertugliflozin) don’t just lower glucose and A1C, but these meds have become relevant in cardiovascular disease and chronic kidney disease in the right patients also with type 2 diabetes (T2DM). In this lecture from This is Why, Dr. Busti will make the SGLT2 inhibitors make sense as they provide cardiorenal protection abo...
Sulfonylureas (Glyburide, Glipizide): Type 2 Diabetes Pharmacology 27.01.2026 22:05
Dr. Busti covers one of the most-tested Type 2 diabetes drug classes—sulfonylureas. If you’ve ever mixed up glyburide vs glipizide, worried about hypoglycemia, or wanted a clear “when do I pick this?” framework, this drug class review is for you. In this lecture from This is Why, Dr. Busti will break down Sulfonylureas (Glyburide, Glipizide) step-by-step so you can confidently in the context of tr...
TZDs (Pioglitazone) for Type 2 Diabetes: Pharmacology Review 27.01.2026 16:15
In this lecture from This is Why, Dr. Busti will break down pioglitazone and the thiazolidinediones (TZDs) so you can confidently explain the mechanism, clinical use, side effects, and key contraindications for type 2 diabetes (T2DM). You’ll learn how to: - TZDs (pioglitazone): where they fit in type 2 diabetes (T2DM) therapy - Mechanism of action: PPAR-γ agonist → increased insulin sensitivity (m...
LABA (Long-Acting Beta Agonists) Bronchodilators for Asthma & COPD 27.01.2026 36:40
In this lecture from This is Why, Dr. Busti will explain how Long-Acting Beta Agonists (LABAs) work, where they fit in therapy for the management of asthma and COPD. You’ll learn how to: - Mechanism of action: beta-2 receptor activation → bronchodilation (airway smooth muscle relaxation) - Clinical use: LABAs in COPD maintenance vs asthma (must be combined with ICS) - Onset/duration differences an...
SABA (Short-Acting Beta Agonists) Bronchodilators for Asthma & COPD 27.01.2026 39:05
In this lecture from This is Why, Dr. Busti will break down SABA (Short-Acting Beta Agonist) bronchodilators, like albuterol, for the acute management of asthma symptoms and COPD flare-ups. You’ll learn how to: - What SABAs are and when they’re used (rescue vs controller) - Beta-2 agonist mechanism of action (bronchodilation and smooth muscle effects) - How fast albuterol works, typical duration,...
Alpha-Glucosidase Inhibitors for Diabetes: Pharmacology Made Easy 26.01.2026 21:22
In this lecture from This is Why, Dr. Busti will teach you about Alpha-Glucosidase Inhibitors for Diabetes — the pharmacology made easy breakdown of acarbose and miglitol for type 2 diabetes. You’ll learn how to: - Explain how alpha-glucosidase inhibitors reduce postprandial hyperglycemia - Identify where these drugs work (GI tract) and why they don’t cause hypoglycemia by themselves - Compare aca...
Amylin Analogs (Pramlintide) for Diabetes: Pharmacology Made Easy 26.01.2026 23:31
Amylin Analogs (Pramlintide) for Diabetes: Pharmacology Made Easy. In this lecture from This is Why, Dr. Busti will explain how pramlintide (Symlin/SymlinPen) works and when it’s used as an adjunct to insulin for type 1 diabetes (and select type 2 diabetes cases). In this diabetes pharmacology review, I break down the mechanism of action of an amylin analog, why it helps postprandial glucose cont...
Metformin - A Biguanide for Type 2 Diabetes: Pharmacology Made Easy 26.01.2026 32:07
Metformin is a first-line oral medication for type 2 diabetes. In this lecture from This is Why, Dr. Busti will explain how metformin works to lower the A1c and help patients with type 2 diabetes get to their A1C goals. You’ll learn how to: - Metformin mechanism of action (MOA): how biguanides lower glucose and improve insulin resistance - Where metformin fits in type 2 diabetes therapy (first-l...
DPP-4 Inhibitors for Type 2 Diabetes: Pharmacology Made Easy 26.01.2026 21:51
In this lecture from This is Why, Dr. Busti will learn about the application of DPP-4 inhibitors in the management of type 2 diabetes mellitus (T2DM). The DPP-4 inhibitors (e.g., sitagliptin, linagliptin, saxagliptin) have an impact of incretins (GIP, GLP-1) which have continued to evolve in other treatment options. You’ll learn how to: - Mechanism of action: DPP-4 inhibition and impact on increti...
Tirzepatide (GIP/GLP-1 Agonists) for Diabetes: Pharmacology Made Easy 26.01.2026 31:51
Tirzepatide (Mounjaro/Zepbound)—the dual incretin GIP/GLP-1 agonist—is a beneficial treatment of type 2 diabetes and/or obesity. In this lecture from This is Why, Dr. Busti will break down how tirzepatide works (MOA), why combining GIP + GLP-1 improves A1C reduction and supports weight loss, and where it fits in the treatment of type 2 diabetes. You’ll also get the high-yield points you need for...
Statins (HMG-CoA Reductase Inhibitors): LDL Lowering Made Easy 20.01.2026 1:03:47
Statins (HMG-CoA Reductase Inhibitors) are the foundation of LDL lowering and ASCVD prevention. In this lecture from This is Why, Dr. Busti will make statin pharmacology easy to understand, but also clinically relevant in the proper context of the evidence. The use of HMG CoA reductase inhibitors: atorvastatin, rosuvastatin, simvastatin, pitavastatin, and pravastatin are drugs in this drug class t...
Omega-3 Fatty Acids (DHA, EPA): Pharmacology Made Easy 20.01.2026 27:05
Omega-3 fatty acids made easy: learn EPA vs DHA, how fish oil works, and when to use icosapent ethyl (Vascepa) in real clinical practice. In this lecture from This is Why, Dr. Busti connects PUFAs (polyunsaturated fatty acids) to outcomes, focusing on triglyceride lowering, cardiovascular risk reduction, and the key differences between OTC fish oil supplements and prescription EPA. You’ll learn ho...
Fibrates (Fenofibrate & Gemfibrozil) for TG: Pharmacology Made Easy 20.01.2026 30:00
Learn fibrates (fibric acid derivatives)—fenofibrate and gemfibrozil—common triglyceride-lowering drugs for hypertriglyceridemia. In this lecture from This is Why, Dr. Busti will break down how fibrates (fenofibrate and gemfibrozil) work, when to use them, and the safety pearls you need for the patient with high triglycerides, which can lead to pancreatitis. You’ll learn how to: - Mechanism: PPAR-...
Ezetimibe (Cholesterol Absorption Inhibitors): Pharmacology Made Easy 20.01.2026 33:30
In this lecture from This is Why, Dr. Busti will break down Ezetimibe (Zetia)—the classic cholesterol absorption inhibitor—and make the pharmacology easy, high-yield, and clinically relevant. You’ll learn how ezetimibe lowers LDL-C, where it fits in dyslipidemia/hyperlipidemia therapy, and how it’s commonly used as add-on therapy to statins. You’ll learn how to: - Mechanism of action: how the chol...
ATP Citrate Lyase (ACL) Inhibitors: Bempedoic Acid Review 20.01.2026 29:54
ATP Citrate Lyase (ACL) Inhibitors made simple. In this lecture from This is Why, Dr. Busti will provide you with a review of Bempedoic Acid (Nexletol), and you’ll learn how this lipid-lowering drug works, when to use it (including statin intolerance), and the key clinical pearls you need for exams and practice. You’ll learn how to: - What ATP citrate lyase inhibitors are and where they work in c...
Platelet Aggregation in Thrombosis: Clinical Essentials 19.01.2026 29:10
Platelet aggregation is a core step in hemostasis—and when it’s dysregulated, it drives thrombosis. In this lecture from This is Why, Dr. Busti will break down platelet physiology in a clear, clinically relevant way so you can understand how platelets form a primary hemostatic plug, how a thrombus develops, and why this process matters in real patient care. You’ll learn how to: - How platelet adhe...
Coagulation Cascade in Thrombosis: Physiology Made Easy 19.01.2026 35:47
Dive into the coagulation cascade with this clear, clinically focused review! In this lecture from This is Why, Dr. Busti breaks down the coagulation cascade in a clear, clinically relevant way—perfect for healthcare professionals preparing for exams or patient care. Dr. Busti specifically covers the basics of hemostasis, the intrinsic and extrinsic pathways, clotting factors, vitamin K-dependent...
P2Y12 Inhibitors (ADP Inhibitors): Antiplatelet Pharmacology Made Easy 16.01.2026 44:08
In this lesson on P2Y12 inhibitors (ADP inhibitors), you’ll learn the high-yield, test-relevant concepts behind the most common antiplatelet drugs used in cardiovascular care. In this lecture from This is Why, Dr. Busti will break down how platelet aggregation inhibitors work, when they’re used clinically, and the key differences between clopidogrel (Plavix), prasugrel (Effient), ticagrelor (Brili...
GPIIb/IIIa Inhibitors: Antiplatelet Pharmacology Made Easy & Relevant 16.01.2026 17:49
In this lesson on glycoprotein (GP) IIb/IIIa (GPIIb/IIIa) inhibitors, you’ll learn the high-yield, test-relevant concepts behind the adjunct antiplatelet drug therapy used in the acute management of patients experiencing an acute myocardial infarction (AMI; NSTEMI, STEMI) and undergoing PCI or coronary stent placement. In this lecture from This is Why, Dr. Busti will break down how platelet aggreg...
Aspirin (ASA): Antiplatelet Pharmacology Made Easy & Relevant 15.01.2026 43:35
Master Aspirin (ASA) fast with this Antiplatelet Pharmacology Made Easy & Relevant lecture. In this lecture from This is Why, Dr. Busti will make sure you learn how acetylsalicylic acid works as an antiplatelet drug, including COX-1 inhibition, decreased thromboxane A2 (TXA2), and reduced platelet aggregation—plus the key clinical takeaways for MI prevention, stroke prevention, and secondary p...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.